Rhabdomyosarcoma 1

Rhabdomyosarcoma (RMS) is a type of cancer that typically arises from skeletal muscle tissue or, less commonly, from non-muscle tissue. It is the most common soft tissue sarcoma found in children, but it can also affect adults. Rhabdomyosarcoma is categorized into several subtypes based on the histological appearance of the tumor cells, with the most common being embryonal, alveolar, and pleomorphic.

Classification

Rhabdomyosarcoma is classified into three main subtypes, each with distinct histological and genetic characteristics:

• Embryonal Rhabdomyosarcoma: This subtype is most common in children and is typically found in the head and neck region, genitourinary tract, and other areas. It tends to have a better prognosis than the other types.
• Alveolar Rhabdomyosarcoma: More common in adolescents, this subtype often affects the extremities and is characterized by a specific chromosomal translocation (t(2;13)(q35;q14)). It is associated with a poorer prognosis.
• Pleomorphic Rhabdomyosarcoma: This rare subtype is mostly seen in adults and is characterized by a more aggressive behavior and poorer outcome.

Symptoms

The symptoms of rhabdomyosarcoma vary depending on the tumor's location but may include a noticeable lump or swelling, pain, and, in some cases, functional impairments. Tumors in the nasal or throat region can lead to difficulty breathing or swallowing, while those in the urinary or reproductive systems might cause urinary or bowel obstruction or bleeding.

Diagnosis

Diagnosis of rhabdomyosarcoma involves a combination of imaging studies, such as MRI or CT scan, and a biopsy of the tumor tissue. Histological examination and molecular genetic testing are crucial for determining the subtype of RMS, which guides treatment decisions.

Treatment

Treatment for rhabdomyosarcoma typically includes a combination of surgery, chemotherapy, and radiation therapy, tailored to the individual's specific type and stage of cancer. The goal of treatment is to remove or destroy the tumor while preserving as much function as possible.

Prognosis

The prognosis for rhabdomyosarcoma depends on several factors, including the subtype, size and location of the tumor, and whether the cancer has spread (metastasized) at the time of diagnosis. Generally, patients with localized disease have a better prognosis than those with metastatic disease.

Epidemiology

Rhabdomyosarcoma is a rare cancer, with an estimated incidence of about 4.5 cases per million children annually. It accounts for approximately 3% of all childhood cancers.

Rhabdomyosarcoma 1 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia